Here are five quick facts:
1. Under the new agreement, the Endoskeleton titanium implants will be available in six countries across Europe: Spain, Portugal, Andorra, Luxembourg, Belgium and the United Kingdom.
2. MBA is an international device making and distribution organization focusing on orthopedic and neurosurgery treatments.
3. Titan Spine opened an office in Valencia, Spain recently to support growth and adoption in Europe. The office supports sales, training and marketing initiatives across Europe in conjunction with the company’s European headquarters in Laichingen, Germany.
4. Over the last few years, and particularly in the first half of this year, Titan has experienced sales growth. “By broadly expanding our line of titanium spinal implants to surgeons and patients in six additional countries across Europe, we have a greater opportunity to offer the benefits of our subtractive surface technology for surgeons and patients in Europe,” said Titan Spine President Kevin Gemas.
5. The full line of Endoskeleton devices features Titan’s proprietary implant surface technology with a unique combination of surface topographies designed for host-bone response and to actively participate in the fusion process.
More articles on orthopedic devices:
Stryker completes Muka Metal acquisition
2 new board members for SI-BONE: 6 key notes
InVivo to present paper at international congress
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
